IP Library › Assignment 017262/0312
Patent Assignment
Reel/Frame 017262/0312

Release of Security Interest

Recorded: 2006-03-07 Received: 2006-03-07 Pages: 12
Assignors
SILVER POINT FINANCE LLC
Executed: 2006-02-28
Assignees
AAIPHARMA LLC
2320 SCIENTIFIC PARK DRIVE, WILMINGTON, NC, 28405, UNITED STATES
AAIPHARMA INC.
2320 SCIENTIFIC PARK DRIVE, WILMINGTON, NC, 28405, UNITED STATES
Covered Properties (33)
Method of treating cancer using dithiocarbamate derivatives
Application: 10/922,728 →
Magnesium-S-omeprazole
Application: 10/855,809 →
Flexible Spinal Stabilization System and Method
Application: 10/793,308 →
Kickdown mechanism
Application: 10/761,638 →
Polyether brevetoxin derivatives as a treatment for neurotoxic shellfish poisoning and ciguatera fish poisoning
Application: 60/504,670 →
Method of reducing the risk of adverse cardiovascular events
Application: 60/499,153 →
Granulated Pharmaceutical Formulations and Methods for Making the Same
Application: 10/439,865 →
Dry Blend Pharmaceutical Formulations
Application: 10/439,438 →
Alkoxy Substituted Benzimidazole Compounds, Pharmaceutical Preparations Containing the Same, and Methods of Using the Same
Application: 10/434,259 →
Dry-Blend Pharmaceutical Formulations
Application: 10/431,019 →
Golf Swing Conditioner
Application: 10/417,441 →
Form a of Fluoxetine Hydrochloride
Application: 10/136,582 →
Alkoxy Substituted Benzimidazole Compounds, Pharmaceutical Preparations Containing the Same, and Methods of Using the Same
Application: 10/189,659 →
Polymorphic form of 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4h-pyrido[1,2-alpha]pyrimidin-4-one and formulations thereof
Application: 10/109,513 →
Polymorphic form of 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-alpha]pyrimidin-4-one and formulations thereof
Application: 10/109,086 →
Polymorphic form of 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-alpha]pyrimidin-4-one and formulations thereof
Application: 10/108,729 →
Alkoxy Substituted Benzimidazole Compounds, Pharmaceutical Preparations Containing the Same, and Methods of Using the Same
Application: 10/057,659 →
Form a of Fluoxetine Hydrochloride
Application: 09/991,839 →
Self-Organizing Mobile Wireless Station Network
Application: 09/968,188 →
Polymorphic Forms of 6-[4-(1-Cyclohexyl-1H-Tetrazol-5-Yl)Butoxy]-3,4-Dihydro-2(1H)-Quinolinone
Application: 09/896,184 →
Polymorphic Forms of 6-[4-(1-Cyclohexyl-1H-Tetrazol-5-Yl)Butoxy]-3,4-Dihydro-2(1H)-Quinolinone
Application: 09/896,065 →
Polymorphic Forms of 6-[4-(1-Cyclohexyl-1H-Tetrazol-5-Yl)Butoxy]-3,4-Dihydro-2(1H)-Quinolinone
Application: 09/896,067 →
Polymorphic Forms of 6-[4-(1-Cyclohexyl-1H-Tetrazol-5-Yl)Butoxy]-3,4-Dihydro-2(1H)-Quinolinone
Application: 09/896,449 →
Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-YL)butoxy]-3,4-dihydro-2(1H)-quinolinone
Application: 09/896,185 →
Polymorphic Forms of 6-[4-(1-Cyclohexyl-1H-Tetrazol-5-Yl)Butoxy]-3,4-Dihydro-2(1H)-Quinolinone
Application: 09/896,800 →
Polymorphic Forms of 6-[4-(1-Cyclohexyl-1H-Tetrazol-5-Yl)Butoxy]-3,4-Dihydro-2(1H)-Quinolinone
Application: 09/896,448 →
Process for Purifying 6- Methoxy Omeprazole
Application: 09/839,449 →
Process for Purifying 6-Methoxy Omeprazole
Application: 09/839,395 →
Form a of fluoxetine hydrochloride
Application: 09/772,968 →
Form A of fluoxetine hydrochloride
Application: 09/773,015 →
Form a of fluoxetine hydrochloride
Application: 09/772,969 →
Form a of fluoxetine hydrochloride
Application: 09/773,016 →
Form a of fluoxetine hydrochloride
Application: 09/772,992 →